Marina Biotech Announces Allowance of Fundamental RNAi Delivery Patent From U.S. Patent Office 0
Posted on
September 01, 2010 by
admin
Marina Biotech Announces Allowance of Fundamental RNAi Delivery Patent From U.S. Patent Office
BOTHELL, WA–(Marketwire – 08/30/10) – Marina Biotech, Inc. (NASDAQ: MRNA – News ), a leading RNAi-based drug discovery and development company, today announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for patent application U.S. 11/745,003 broadly covering amphoteric liposomal formulations, including the Company’s proprietary SMARTICLES technology, for delivery …
Read more on Marketwire via Yahoo! Finance
